June 02, 2026
Eli Lilly & Co. cited two circuit opinions this week as it defended the legality of halting the flow of discounted drugs under the 340B pricing program for safety net hospitals that won't hand over claims data. Law360 takes a closer look at the cases and decisions Eli Lilly is relying on.
January 30, 2023
Drugmakers don't have to sell their products at a discount through an unlimited number of retail pharmacies just because those pharmacies partnered with health care providers for low-income or uninsured patients under a federal program, the Third Circuit ruled Monday.
November 15, 2022
The limited number of hospitals with in-house pharmacies serving underprivileged communities meant a federal drug discount program had to gradually expand to include retail pharmacies, and that program should bar drugmakers from restricting which pharmacies can order the discounted drugs, an attorney for the U.S. Department of Health and Human Services argued to a Third Circuit panel Tuesday.
November 03, 2022
The Third Circuit's pre-Thanksgiving menu has the court digging into whether an Uber driver can dodge arbitration of his wage suit and whether drug companies have to offer discount prices to pharmacies that contract with hospitals in impoverished areas.
October 31, 2022
In the inaugural edition of Law360's monthly preview of appellate arguments worth watching, Law360 breaks down an epic antitrust case challenging Apple's limitations on its App Store, a 3-D printed gun fight that has seen Fifth Circuit judges complain about a lack of comity between circuits, and a power pricing faceoff that implicates the limits of bankruptcy court jurisdiction.
May 17, 2022
Five hospital groups threw their support behind a federal drug-discounting program being challenged by Sanofi-Aventis and Novo Nordisk, telling the Third Circuit in an amicus brief Tuesday that the pharmaceutical giants can afford what has become an "indispensable lifeline" for health care providers.